Perseverance: We Should Continue to Strive for Novel Antibiotics and Companion Diagnostics

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Antibiotic resistance is an inevitable consequence of antibiotic use, posing a significant threat to global health.
• Current medical guidelines and diagnostic practices are insufficient to address the escalating challenge of antibiotic resistance.
• The pipeline for novel antibiotics and companion diagnostics is fragile, requiring urgent attention and investment.

Purpose of the Study:

• To highlight the gaps in current outpatient antibiotic stewardship and diagnostic practices using a clinical case.
• To emphasize the urgent need for updated guidelines, improved diagnostic methods, and sustained investment in antibiotic research and development.

Main Methods:

• A case study of recurrent Group C streptococcal pharyngitis in a family was used to illustrate practical challenges.
• The viewpoint discusses the implications of these challenges in an outpatient setting.

Main Results:

• The case demonstrated critical gaps between clinical needs and existing diagnostic and treatment guidelines for recurrent infections.
• The findings underscore the inadequacy of current practices in managing antibiotic resistance in common infections.

Conclusions:

• Updated, accessible guidelines, routine culturing upon relapse, and public education are essential to combat antibiotic resistance.
• Sustained investment in novel antibiotics and companion diagnostics, supported by fair pricing, is crucial for future public health.
• Addressing the antibiotic resistance crisis requires a multi-faceted approach involving healthcare providers, policymakers, and the public.